Milestone Pharmaceuticals Inc. - COM (MIST)

Historical Portfolio Holders from Q2 2019 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
30.2M
Holdings value Q2 2024
$39.9M
Value change Q2 2024
-$1.77M
Grand Portfolio weight change Q2 2024
0%
Number of holders
39
Number of buys Q2 2024
11
Number of sells Q2 2024
-12
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 30.2M $39.9M -$1.77M $1.32 40
2024 Q1 31.1M $55.6M +$23.7M $1.79 40
2023 Q4 17.8M $29.7M -$3.46M $1.67 37
2023 Q3 19.4M $60M -$3.31M $3.10 37
2023 Q2 20.5M $58.3M -$3.17M $2.85 46
2023 Q1 21.5M $84.7M -$10.2M $3.94 47
2022 Q4 23.7M $93.7M -$29.5M $3.96 53
2022 Q3 20.4M $187M +$9.68M $9.19 42
2022 Q2 20.8M $127M -$2.81M $6.14 28
2022 Q1 20.2M $130M +$5.07M $6.42 26
2021 Q4 19.4M $127M +$2M $6.55 25
2021 Q3 19.9M $114M -$1.09M $5.71 29
2021 Q2 20.1M $111M -$855K $5.50 30
2021 Q1 20.3M $117M -$1.99M $5.79 31
2020 Q4 20.6M $138M +$34M $6.70 32
2020 Q3 15.5M $113M +$42.8M $7.32 28
2020 Q2 9.74M $36.8M +$2.94M $3.78 22
2020 Q1 9.23M $17M -$32.7M $1.84 15
2019 Q4 14.4M $230M +$20.2M $16.01 23
2019 Q3 13.1M $240M -$2.84M $18.65 22
2019 Q2 13.1M $350M +$350M $27.15 23